Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Amalia Guadalupe Becerra Aquino"'
Autor:
Scott A Halperin, Lingyun Ye, Donna MacKinnon-Cameron, Bruce Smith, Pedro E Cahn, Guillermo M Ruiz-Palacios, Aamer Ikram, Fernando Lanas, M Lourdes Guerrero, Sergio Raúl Muñoz Navarro, Omar Sued, Dmitry A Lioznov, Vitalina Dzutseva, Ghazala Parveen, Fengcai Zhu, Laura Leppan, Joanne M Langley, Luis Barreto, Jinbo Gou, Tao Zhu, Helen Mao, Luc Gagnon, Steven-Phay Tran, Sarwat Tahsin Khan, Amalia Guadalupe Becerra Aquino, Edgar Eduardo Saldaña Montemayor, Norma Eréndira Rivera Martínez, Víctor Casildo Bohórquez López, J. Abraham Simón Campos, Felipe de Jesús Pineda Cárdenas, Wei Chen, Lihua Hou, Zhe Zhang, Gonzalo Corral, Eduardo López, Ricardo Teijeiro, Maria F. Alzogaray, Cesar Zaidman, Gustavo Lopardo, Bernardo Goecke, Rosa María Feijooó Seoane, Sayed Faisal Mahmood, Ejaz Ahmed Khan, Jayed Akram, Salma Abbas, Naseem Salahuddin, Elena Rozhkova, Tatyana Zubkova
Publikováno v:
Lancet (London, England)
Background The Ad5-nCoV vaccine is a single-dose adenovirus type 5 (Ad5) vectored vaccine expressing the SARS-CoV-2 spike protein that was well-tolerated and immunogenic in phase 1 and 2 studies. In this study, we report results on the final efficacy
Autor:
Mercedes Macias, Eric Plennevaux, Juan Francisco Galán Herrera, Carlos E. Aranza Doniz, Betzana Zambrano, Eduardo Santos-Lima, Maricruz Gutiérrez Brito, Amalia Guadalupe Becerra Aquino
Publikováno v:
Vaccine. 30:6492-6500
To evaluate an investigational, fully liquid hexavalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus-hepatitis B-Haemophilus influenzae type b (DTaP-IPV-Hep B-PRP-T: Hexaxim™) vaccine for primary and booster vaccination of healthy